MeSH tree: C08.381.540.140
The need for more effective lung cancer treatments is paramount, as the disease remains a leading cause of cancer deaths in the United States. New findings by a research team from the Stony Brook Cancer Center highlight a ...
Aug 4, 2026
0
6
Ever notice how chatbots often insist on making up an answer instead of admitting defeat? Like a student desperately scribbling nonsense to avoid handing in a blank page, large language models (LLMs) seem to live by the make-it-up-as-you-go ...
Jul 31, 2026
0
4
New research has shown that RNA-based testing can improve the detection and interpretation of clinically actionable genomic alterations that lead to MET exon 14 skipping in patients with lung cancer—important biomarkers that ...
Jul 23, 2026
0
3
Who doesn't want cancer testing results at lower cost, with greater speed and accuracy? Interdisciplinary innovators like Cancer Center at Illinois (CCIL) program leader Brian Cunningham are among the pioneers of the emerging ...
Jul 21, 2026
0
6
A research team led by experts at Roswell Park Comprehensive Cancer Center has documented new evidence that excess abdominal fat increases the risk of developing non-small cell lung cancer. Published in the Journal of Thoracic ...
Jul 8, 2026
0
6
Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for thousands of patients with lung cancer driven by a rare type of KRAS mutation, offering hope for ...
Jul 7, 2026
0
6
A research team led by Prof. Liu Qingsong at the Institute of Health and Medical Technology, the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has discovered a new drug candidate that may help overcome ...
Jun 25, 2026
0
3
Medical artificial intelligence (AI) faces a fundamental challenge: uncertainty quantification. Artificial neural networks are largely unaware of the limits of their training data and can become overconfident when confronted ...
Jun 23, 2026
0
6
Even as biomarker testing has become increasingly important for selecting the right lung cancer treatment, the time it takes to order these tests hasn't improved. Overall, the time from biopsy to biomarker results is about ...
Jun 22, 2026
0
8
An experimental antibody treatment that binds to a protein known as PCDH7 shrank tumors in preclinical models of non-small cell lung cancer (NSCLC), including those resistant to a targeted therapy, a study led by UT Southwestern ...
Jun 11, 2026
0
8
